LBF18207HP03: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
|Common Name=&&Methyl-13,15-Epidioxy-16-Hydroperoxy-9,11-Octadecadienoate&& | |Common Name=&&Methyl-13,15-Epidioxy-16-Hydroperoxy-9,11-Octadecadienoate&& | ||
|Mass Spectra=GC-EI-MS(after reduction(PH3P) and TMS-derivatization)[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]]: m/e=397[M-CH3], 131[SMTO=CHCH2CH3]; GC-EI-MS(after reduction(NaBH4 or KI) and TMS-derivatization)[[Reference:Frankel_EN:Neff_WE:Rohwedder_WK:Khambay_BPS:Garwood_RF:Weedon_BCL:,Lipids,1977,12,1055|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:Neff_WE:Rohwedder_WK:Khambay_BPS:Garwood_RF:Weedon_BCL:,Lipids,1977,12,1055}}]]: m/e=311[SMTO=CH-CH=CH-CH=CH-(CH2)7COOCH3]; 131[SMTO=CHCH2CH3] | |Mass Spectra=GC-EI-MS(after reduction(PH3P) and TMS-derivatization)[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]]: m/e=397[M-CH3], 131[SMTO=CHCH2CH3]; GC-EI-MS(after reduction(NaBH4 or KI) and TMS-derivatization)[[Reference:Frankel_EN:Neff_WE:Rohwedder_WK:Khambay_BPS:Garwood_RF:Weedon_BCL:,Lipids,1977,12,1055|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:Neff_WE:Rohwedder_WK:Khambay_BPS:Garwood_RF:Weedon_BCL:,Lipids,1977,12,1055}}]]: m/e=311[SMTO=CH-CH=CH-CH=CH-(CH2)7COOCH3]; 131[SMTO=CHCH2CH3] | ||
|UV Spectra=Conjugated cis, trans diene: | |UV Spectra=Conjugated cis, trans diene: lambdamax=234-237nm, conjugated trans, trans diene: lambdamax=231-234nm [[Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84|{{RelationTable/GetFirstAuthor|Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84}}]][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]][[Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365|{{RelationTable/GetFirstAuthor|Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365}}]][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]][[Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235|{{RelationTable/GetFirstAuthor|Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235}}]] | ||
|IR Spectra=OOH group: 3720-3140cm | |IR Spectra=OOH group: 3720-3140cm^- ^1 [bonded], 3530-3520cm^- ^1 [FREE]; olefinic protons: 3020-3000cm^- ^1 ; conjugated cis, trans diene : 989-980cm^- ^1 , 955-947cm^- ^1 ; conjugatedtrans, trans diene: 992-984cm^- ^1 , 955cm^- ^1 [[Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84|{{RelationTable/GetFirstAuthor|Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84}}]][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]][[Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365|{{RelationTable/GetFirstAuthor|Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365}}]][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]][[Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952}}]][[Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235|{{RelationTable/GetFirstAuthor|Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235}}]] | ||
|NMR Spectra= | |NMR Spectra=^1 H-NMR[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]][[Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365|{{RelationTable/GetFirstAuthor|Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365}}]][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]][[Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235|{{RelationTable/GetFirstAuthor|Reference:Chan_HWS:Matthew_JA:Coxon_DT:,J. Chem. Soc. Chem. Commun.,1980,,235}}]]: C9: 5.46-5.78; C10: 5.99-6.05; C11: 6.26-6.67; C12: 5.53- 5.62; C13: 4.75-4.84; C14: 2.23-2.47, 2.79-2.88; C15: 4.47-4.49; C16: 3.86-4.15; OOH: 8.98-9.55ppm; J9-15=10.0-11.0[cis]; J9-10=15.1-15.5[trans]; J11-12=14.5-15.4Hz[trans] | ||
|Source=Auto oxydation of linoleate[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]][[Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365|{{RelationTable/GetFirstAuthor|Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365}}]]. Oxydation of linoleate in the presence of Fe(III)-ascorbic acid[[Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84|{{RelationTable/GetFirstAuthor|Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84}}]]. Photoenhancemant of linoleate peroxydation[Type II][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]][[Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952}}]]. Production mechanism[[Reference:Frankel_EN:,Prog. Lipid Res.,1984,23,197|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:,Prog. Lipid Res.,1984,23,197}}]][[Reference:Frankel_EN:,Chem. Phys. Lipids,1987,44,73|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:,Chem. Phys. Lipids,1987,44,73}}]]. | |Source=Auto oxydation of linoleate[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1981,16,439}}]][[Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365|{{RelationTable/GetFirstAuthor|Reference:Coxon_DT:Price_KR:Chan_HWS:,Chem. Phys. Lipids,1981,28,365}}]]. Oxydation of linoleate in the presence of Fe(III)-ascorbic acid[[Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84|{{RelationTable/GetFirstAuthor|Reference:Toyoda_I:Terao_J:Matsushita_S:,Lipids,1982,17,84}}]]. Photoenhancemant of linoleate peroxydation[Type II][[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]][[Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:,Lipids,1984,19,952}}]]. Production mechanism[[Reference:Frankel_EN:,Prog. Lipid Res.,1984,23,197|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:,Prog. Lipid Res.,1984,23,197}}]][[Reference:Frankel_EN:,Chem. Phys. Lipids,1987,44,73|{{RelationTable/GetFirstAuthor|Reference:Frankel_EN:,Chem. Phys. Lipids,1987,44,73}}]]. | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Revision as of 23:00, 19 February 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | DFA8057 |
LipidMaps | LMFA01040041 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF18207HP03 |
Methyl-13,15-Epidioxy-16-Hydroperoxy-9,11-Octadecadienoate | |
---|---|
![]() | |
Structural Information | |
Methyl-13,15-Epidioxy-16-Hydroperoxy-9,11-Octadecadienoate | |
| |
Formula | C19H32O6 |
Exact Mass | 356.219888756 |
Average Mass | 356.45378 |
SMILES | C(O1)(CC(C=CC=CCCCCCCCC(=O)OC)O1)C(CC)OO |
Physicochemical Information | |
Auto oxydation of linoleate Neff_WE et al. Coxon_DT et al.. Oxydation of linoleate in the presence of Fe(III)-ascorbic acid Toyoda_I et al.. Photoenhancemant of linoleate peroxydation[Type II] Neff_WE et al. Neff_WE et al.. Production mechanism Frankel_EN Frankel_EN . | |
It reacts with DNA in the presence of Fe ions and ascorbic acid Fujimoto_K et al.. | |
Major secondary products of linolenate by autooxidation Frankel_EN Neff_WE et al.. It is formed through 1, 3 cyclization of 13-peroxy radical of linolenate Frankel_EN Frankel_EN Frankel_EN Chan_HWS et al. Coxon_DT et al.. | |
Spectral Information | |
Mass Spectra | GC-EI-MS(after reduction(PH3P) and TMS-derivatization) Neff_WE et al.: m/e=397[M-CH3], 131[SMTO=CHCH2CH3]; GC-EI-MS(after reduction(NaBH4 or KI) and TMS-derivatization) Frankel_EN et al.: m/e=311[SMTO=CH-CH=CH-CH=CH-(CH2)7COOCH3]; 131[SMTO=CHCH2CH3] |
UV Spectra | Conjugated cis, trans diene: lambdamax=234-237nm, conjugated trans, trans diene: lambdamax=231-234nm ToyodaIet al. Neff_WE et al. Coxon_DT et al. Neff_WE et al. Chan_HWS et al. |
IR Spectra | OOH group: 3720-3140cm-1[bonded], 3530-3520cm-1[FREE]; olefinic protons: 3020-3000cm-1; conjugated cis, trans diene : 989-980cm-1, 955-947cm-1; conjugatedtrans, trans diene: 992-984cm-1, 955cm-1 ToyodaIet al. Neff_WE et al. Coxon_DT et al. Neff_WE et al. Neff_WE et al. Chan_HWS et al. |
NMR Spectra | 1H-NMR Neff_WE et al. Coxon_DT et al. Neff_WE et al. Chan_HWS et al.: C9: 5.46-5.78; C10: 5.99-6.05; C11: 6.26-6.67; C12: 5.53- 5.62; C13: 4.75-4.84; C14: 2.23-2.47, 2.79-2.88; C15: 4.47-4.49; C16: 3.86-4.15; OOH: 8.98-9.55ppm; J9-15=10.0-11.0[cis]; J9-10=15.1-15.5[trans]; J11-12=14.5-15.4Hz[trans] |
Other Spectra | |
Chromatograms |
[hide]Reported Metabolites, References | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|